✦ LIBER ✦

A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer

✍ Scribed by Francesco Grossi; Filippo de Marinis; Vittorio Gebbia; Ferdinando Riccardi; Orazio Caffo; Teresa Gamucci; Francesco Ferraù; Mario Nardi; Luca Moscetti; Luca Boni; Davide Dondi; Enzo Galligioni

Publisher: Springer
Year: 2011
Tongue: English
Weight: 241 KB
Volume: 69
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-011-1710-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II randomized trial of gemcitabi

A phase II randomized trial of gemcitabine-docetaxel versus gemcitabine-cisplatin in patients with advanced non-small cell lung carcinoma

✍ Joaquín Casal Rubio; S. Vázquez; F. Vázquez; M. Amenedo; J. L. Fírvida; J. R. Me 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 255 KB

Phase II study with fractionated schedul

Phase II study with fractionated schedule of docetaxel and cisplatin in patients with advanced non-small cell lung cancer

✍ Jung Hye Kwon; Jung Han Kim; Jung-Ae Lee; Hyun Chun Shin; Hyo Jung Kim; Hun Ho S 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 193 KB

Docetaxel/gemcitabine or cisplatin/gemci

Docetaxel/gemcitabine or cisplatin/gemcitabine followed by docetaxel in the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC): results of a multicentre randomized phase II trial

✍ D. Binder; H. Schweisfurth; C. Grah; C. Schäper; B. Temmesfeld-Wollbrück; G. Sie 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 340 KB

A triplet chemotherapy with cisplatin, d

A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study

✍ Masahiro Tabata; Toshiyuki Kozuki; Hiroshi Ueoka; Katsuyuki Kiura; Shingo Harita 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 276 KB

Phase II study of weekly docetaxel combi

Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

✍ Toshiyuki Tsunoda; Tomonobu Koizumi; Muneharu Hayasaka; Kazuya Hirai; Shigeru Ko 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 180 KB

Phase II trial of gemcitabine and doceta

Phase II trial of gemcitabine and docetaxel in patients with completely resected stage IIA–IIIA non-small-cell lung cancer

✍ Masafumi Kawamura; Keisuke Eguchi; Yotaro Izumi; Yasushi Yamato; Teruaki Koike; 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 280 KB